HomeCGTX • NASDAQ
add
Cognition Therapeutics Inc
Previous close
$1.92
Day range
$1.90 - $2.02
Year range
$0.90 - $3.49
Market cap
78.67M USD
Avg Volume
134.30K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 15.19M | 63.32% |
Net income | -8.14M | -57.10% |
Net profit margin | — | — |
Earnings per share | -0.27 | -35.00% |
EBITDA | -15.16M | -63.44% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 29.92M | -28.01% |
Total assets | 35.16M | -30.27% |
Total liabilities | 10.69M | 5.04% |
Total equity | 24.47M | — |
Shares outstanding | 39.00M | — |
Price to book | 2.53 | — |
Return on assets | -102.72% | — |
Return on capital | -137.15% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -8.14M | -57.10% |
Cash from operations | -5.46M | 46.43% |
Cash from investing | -30.00K | -200.00% |
Cash from financing | 2.44M | -52.57% |
Net change in cash | -3.05M | 39.64% |
Free cash flow | -8.23M | 29.18% |
About
Founded
Jan 1, 2007
Headquarters
Website
Employees
25